JULUCA FDA approval date

The FDA approved JULUCA on 21 Nov 2017.

FDA approval date
21 Nov 2017

Drug identity has not yet been verified against registry records

Also recorded as DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2017-11-21DayJULUCAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA210192", "applicant_as_listed_by_fda": "VIIV HLTHCARE", "brand_names": ["JULUCA"], "active_ingredients": ["DOLUTEGRAVIR SODIUM", "RILPIVIRINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20171121", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026